Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Lakkis

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Statistics in Medicine|May 3, 2014
Comments on 'sample size calculation for comparing two negative binomial rates'H Zhu, H Lakkis
Annals of Emergency Medicine|February 1, 1997
Efficacy of nebulized ipratropium in severely asthmatic childrenF Qureshi, A Zaritsky, H Lakkis
Biometrics|July 6, 2000
Estimation of exploitation rate by combining mark-recapture procedures with a creel surveyR C Dahiya, S Saha, H Lakkis
Pharmacotherapy|November 1, 1996
Vancomycin-binding characteristics in patients with serious infectionsL Li, M V Miles, H Lakkis, et al.
Therapeutic Drug Monitoring|June 1, 1997
Special considerations for monitoring vancomycin concentrations in pediatric patientsM V Miles, L Li, H Lakkis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 1998
Seroprevalence of Norwalk virus and Mexico virus in Chilean individuals: assessment of independent risk factors for antibody acquisitionM L O'Ryan, P A Víal, N Mamani, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Statistics in Medicine|May 3, 2014
Comments on 'sample size calculation for comparing two negative binomial rates'H Zhu, H Lakkis
Annals of Emergency Medicine|February 1, 1997
Efficacy of nebulized ipratropium in severely asthmatic childrenF Qureshi, A Zaritsky, H Lakkis
Biometrics|July 6, 2000
Estimation of exploitation rate by combining mark-recapture procedures with a creel surveyR C Dahiya, S Saha, H Lakkis
Pharmacotherapy|November 1, 1996
Vancomycin-binding characteristics in patients with serious infectionsL Li, M V Miles, H Lakkis, et al.
Therapeutic Drug Monitoring|June 1, 1997
Special considerations for monitoring vancomycin concentrations in pediatric patientsM V Miles, L Li, H Lakkis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 1998
Seroprevalence of Norwalk virus and Mexico virus in Chilean individuals: assessment of independent risk factors for antibody acquisitionM L O'Ryan, P A Víal, N Mamani, et al.
Pageof 1